Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03263117 · ClinicalTrials.gov registry record · Phase 4

SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke

A Phase 4 study of Stroke, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 4
Development phase
260
Enrollment target
11
Study locations

NCT03263117 is a Phase 4 study of Stroke that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 260 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 11 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03263117, a Phase 4 study of Stroke, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 4
Development phase
260 participants
Enrollment target
11
Study locations

Study Summary

Objectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of symptomatic intracranial hemorrhage); rates of Endovascular therapy (EVT) procedural complications, reperfusion; and quality of life. Hypothesis: GA during EVT for acute ischemic stroke improves functional outcomes at 90 days compared to sedation.

Conditions Studied

Stroke

Interventions

  • DRUG Sedation
  • DRUG General Anesthesia (GA)
  • PROCEDURE Intra-arterial Thrombectomy

Study Locations (11)

Texas

  • Memorial Hermann Hospital System - Memorial City Medical Center - Houston
  • Baylor College of Medicine - Houston
  • University of Texas Health Science Center Houston with Memorial Hermann Hospital System - The Medical Center - Houston
  • Memorial Hermann Hospital System - The Woodlands Medical Center - The Woodlands

Pennsylvania

  • Geisinger Health - Danville
  • Temple University - Philadelphia

Indiana

  • Indiana University College of Medicine - Indianapolis

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Kentucky

  • Henry Ford Health System - Louisville

New York

  • Rochester Regional Health - Rochester

North Carolina

  • Wake Forest Baptist Health - Winston-Salem

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2018-07-01
Est. Completion 2023-04-22
Phase Phase 4

Sponsor

The University of Texas Health Science Center, Houston

732 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03263117

The ClinicalTrials.gov registry entry for NCT03263117 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Sedation is the first listed.

NCT03263117 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Texas, Pennsylvania, Indiana.

Frequently Asked Questions

What is clinical trial NCT03263117 about?

NCT03263117 is a clinical study titled "SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke". Objectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of symptomatic intracran...

What is the current status of trial NCT03263117?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 260 participants. The study started on 2018-07-01. Estimated completion is 2023-04-22.

What conditions does trial NCT03263117 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT03263117?

The interventions under investigation include: Sedation (DRUG), General Anesthesia (GA) (DRUG), Intra-arterial Thrombectomy (PROCEDURE).

Who is sponsoring clinical trial NCT03263117?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03263117 being conducted?

This trial has 11 study locations across Indiana, Iowa, Kentucky, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.